Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for Pain Management and Neuroprotection in Contact Sports
NCT06204003Phase 1Completed
- Sponsor
- University of Regina
- Start
- Feb 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cannabidiol in concussion (mTBI) and pain, sponsored by University of Regina. Primary endpoints: Change in cerebrovascular and cardiovascular physiology and Incidence of potential harmful side effects. Started Feb 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
concussion (mTBI)pain
Beyond the preview
Go deeper on NCT06204003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06204003.